Regencell Bioscience Holdings Ltd (RGC) stock
RGCNasdaqMedicinal Chemicals & Botanical Products
$4.55−0.17 (-3.60%)
Close on Nov 17, 2026Market cap $2.26BP/E –Yield –
Regencell Bioscience total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
No total debt figures for Regencell Bioscience
Regencell Bioscience has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?